Calcinase Nasal Spary 3.7 ml
CIPLA LTD
CALCITONIN SALMON
NASAL
In Stock
Calcinase Nasal Spary 3.7 ml belongs to groups of medications called hypocalcemic agents, primarily indicated for the treatment of postmenopausal osteoporosis in women more than five years postmenopause when alternative therapies are unsuitable. Post-menopausal osteoporosis is a medical condition that causes thinning and weakening of the bones during/after a menopausal period.
Calcinase Nasal Spary 3.7 ml contains Calcitonin, a human hormone that prevents bone breakdown and increases bone density (thickness). Thus it helps to treat osteoporosis in postmenopausal women.
Use Calcinase Nasal Spary 3.7 ml as prescribed by the doctor. Calcinase Nasal Spary 3.7 ml may cause certain side effects such as hypocalcemia, runny nose, nosebleed, sinus pain, application site reactions such as rhinitis (stuffy nose), epistaxis (nose bleeds) and other nasal symptoms, back pain, arthralgia (Joint pain) and headache. Most of these side effects do not require medical attention and gradually resolve over time. However, if these side effects persist longer, please consult your doctor.
Calcinase Nasal Spary 3.7 ml is for intranasal use only, do not inject or take it orally. Before using Calcinase Nasal Spary 3.7 ml, inform your doctor of all your medical conditions, sensitivities, and all medications you are using. Calcinase Nasal Spary 3.7 ml is intended for post-menopausal women; therefore, Calcinase Nasal Spary 3.7 ml should not be recommended for other populations. Avoid drinking alcohol because it affects how the body absorbs calcium and vitamin D, which are essential for good bone formation.
Postmenopausal osteoporosis
Calcinase Nasal Spary 3.7 ml contains Calcitonin, a calcitonin receptor agonist that prevents the loss of bones that happens after menopause and helps to rebuild bones. Calcitonin is a hormone that the C-cells in the thyroid gland produce and release. It opposes the parathyroid hormone's action, helping regulate the blood’s calcium and phosphate levels. Calcinase Nasal Spary 3.7 ml works by suppressing the activity of the osteoclasts (cells that break down bone). When the osteoclasts break down bone tissue, the calcium enters the bloodstream. Calcinase Nasal Spary 3.7 ml lessens the amount of calcium in the blood by preventing the breakdown of bone. Thereby, Calcinase Nasal Spary 3.7 ml strengthens the bones and minimizes the risk of fractures. Calcinase Nasal Spary 3.7 ml also seems to decrease the amount of calcium the kidneys can re-absorb, lowering calcium levels further.
Before using Calcinase Nasal Spary 3.7 ml, Inform your doctor about all your medical conditions, sensitivities, and all medications you are using. Calcinase Nasal Spary 3.7 ml is intended for post-menopausal women; therefore, Calcinase Nasal Spary 3.7 ml should not be recommended for other populations. In rare situations, individuals using Calcinase Nasal Spary 3.7 ml may be affected with anaphylactic shock (a sudden, severe, life-threatening allergic reaction leading to difficulty breathing); if you encounter it, stop using Calcinase Nasal Spary 3.7 ml and contact your doctor immediately.
Drug-Drug interactions: Calcinase Nasal Spary 3.7 ml may interact with certain medicines used to treat mood disorders (e.g. lithium), medicines used to treat secondary hyperparathyroidism (e.g. etelcalcetide) and antiviral medications (e.g. foscarnet).
Drug-Food interactions: No interactions found.
Drug-Disease interactions: Calcinase Nasal Spary 3.7 ml interacts with disease conditions, including hypocalcaemia (low calcium level) and mineral metabolism disorder.
Consuming alcohol is not advisable; it affects how the body absorbs calcium and vitamin D, both of which are essential for good bone formation.
Calcinase Nasal Spary 3.7 ml is intended for postmenopausal women only. So, it is not recommended for use in pregnancy.
Calcinase Nasal Spary 3.7 ml is intended for postmenopausal women only. So, it is not recommended for use in breastfeeding women.
Calcinase Nasal Spary 3.7 ml does not impact your ability to drive or operate machinery.
Limited information is available on the use of Calcinase Nasal Spary 3.7 ml in patients with liver disease. Inform your doctor before receiving the Calcinase Nasal Spary 3.7 ml if you have a history of liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Limited information is available about using Calcinase Nasal Spary 3.7 ml in patients with liver disease. Inform your doctor before receiving the Calcinase Nasal Spary 3.7 ml if you have a history of liver impairment. Your doctor will prescribe only if the benefits outweigh the risks.
Calcinase Nasal Spary 3.7 ml is intended for postmenopausal women only. So, it is recommended not to use it in children.
This item is Not Returnable.
Expires on or after - Apr-24
Postmenopausal osteoporosis: Postmenopausal osteoporosis is a medical disorder that causes bone loss and weakness during and after menopause. Estrogen insufficiency increases the risk of developing osteoporosis (weak bones). The decline in oestrogen during the menopause era (45 years of age) causes more bone resorption (osteoclasts; bone disintegration) than creation (osteoblasts; new bone development), leading to osteoporosis. Osteoporosis has no symptoms in the early stages. Yet, if sufficient care is not given, it might result in shattered bones. The bones do not pain at first, and breaks in the spine's bones may go unnoticed until they cause height reduction. Bones with osteoporosis might shatter at any time, even during normal tasks such as lifting or small activities.
India
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
MRP ₹1953
15%off(Inclusive of all taxes)
Provide Delivery Location
Bottle
3.7 ml Spray in 1 Bottle